K M C Speciality Hospitals (India) cash flow

Latest FY24

Cash from operations: ₹38.4cr
Free cash flow: ₹38.4cr
Cash from financing: ₹20.5cr
Cash from investing: −₹55.9cr

₹ crore except per share

Tap a line for its trend	FY24Mar 2024	FY23Mar 2023	FY22Mar 2022	FY21Mar 2021	FY20 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items					FY20 and earlierEvery year the company has filed comes with Alpha Plus.
	9.2	—	6.5	6.2
	1.2	—	0.7	1.0
	−1.8	—	−1.2	−0.5
	0.2	—	−0.1	0.5
	−0.0	—	−1.4	−1.1
	1.1	—	0.2	0.9
Cash from operating activities
	40.6	36.0	32.1	18.0
	48.5	—	38.3	28.2
	10.1	—	9.2	2.6
	38.4	—	29.1	25.6
Cash from investing activities
	0.0	—	0.1	—
	2.3	—	0.9	0.4
	−55.9	—	−28.5	−42.6
Cash from financing activities
	35.6	—	1.3	23.0
	7.7	—	1.4	3.8
	1.5	—	0.5	0.5
	—	—	0.5	0.8
	20.5	—	−1.1	18.0
	3.0	—	—	1.0
	4.8	—	1.7	2.1
Reference items
	47.4	41.3	37.2	23.2
	26.8%	26.5%	27.3%	22.6%
	38.4	—	29.1	25.6
	—	—	29.8	—
	₹2.35	—	₹1.78	₹1.57
	1.26×	—	1.23×	2.00×
	10.1	—	9.2	2.6
	—	—	0.5	0.8

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

KMCSHIL₹149.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health

₹ CrorePeersDRAGARWQ KOVAI LOTUSEYE GPTHEALTH GKSL SHALBY INDRAMEDCO ARTEMISMEDMcap ₹2,439 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY21 31/03/2021	FY22 31/03/2022	FY23 31/03/2023	FY24 31/03/2024
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	6.2	6.5	—	9.2
+ Finance Costs	1.0	0.7	—	1.2
+ Interest Income	-0.5	-1.2	—	-1.8
Changes in Working Capital
+ Inventories	0.5	-0.1	—	0.2
+ Trade Receivables — Current	-1.1	-1.4	—	-0.0
+ Trade Payables — Current	0.9	0.2	—	1.1
Cash from Operating Activities
Profit Before Tax (per I/S)	18.0	32.1	36.0	40.6
Cash from Operations (pre-tax)	28.2	38.3	—	48.5
+ Income Taxes Paid	2.6	9.2	—	10.1
Cash from Operating Activities	25.6	29.1	—	38.4
Cash from Investing Activities
+ Disp of Fixed Assets	—	0.1	—	0.0
+ Interest Received — Investing	0.4	0.9	—	2.3
Cash from Investing Activities	-42.6	-28.5	—	-55.9
Cash from Financing Activities
+ Proceeds from Borrowings	23.0	1.3	—	35.6
+ Repayment of Borrowings	3.8	1.4	—	7.7
+ Payment of Lease Liabilities	0.5	0.5	—	1.5
+ Interest Paid	0.8	0.5	—	—
Cash from Financing Activities	18.0	-1.1	—	20.5
Net Changes in Cash	1.0	—	—	3.0
Closing Cash	2.1	1.7	—	4.8
Reference Items
EBITDA	23.2	37.2	41.3	47.4
EBITDA Margin %	22.64	27.32	26.53	26.75
Free Cash Flow (CFO − Capex)	25.6	29.1	—	38.4
Free Cash Flow to Equity	—	29.8	—	—
Free Cash Flow per Basic Share	1.57	1.78	—	2.35
Cash Flow to Net Income	2.00	1.23	—	1.26
Cash Paid for Taxes	2.6	9.2	—	10.1
Cash Paid for Interest	0.8	0.5	—	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.